this medication 750 represents a remarkable illustration within the enzymatic pharmacy realm . Its mechanism of effect fundamentally modulates cyclooxygenase catalysts , specifically COX-1 , reducing the generation of prostaglandins . Considering a cellular analysis, Relafen's therapeutic potential copyrights on the power to preferentially inhibit